4.6 Article

Depressive Symptoms in Crohn's Disease: Relationship with Immune Activation and Tryptophan Availability

期刊

PLOS ONE
卷 8, 期 3, 页码 -

出版社

PUBLIC LIBRARY SCIENCE
DOI: 10.1371/journal.pone.0060435

关键词

-

资金

  1. European Community [HEALTH-F2-2009-241909]

向作者/读者索取更多资源

Crohn's disease (CD) is associated with immune activation and depressive symptoms. This study determines the impact of anti-tumor necrosis factor (TNF)-alpha treatment in CD patients on depressive symptoms and the degree to which tryptophan (TRP) availability and immune markers mediate this effect. Fifteen patients with CD, eligible for anti-TNF-alpha treatment were recruited. Disease activity (Harvey-Bradshaw Index (HBI), Crohn's Disease Activity Index (CDAI)), fatigue (Multidimensional Fatigue Inventory (MFI)), quality of life (Inflammatory Bowel Disease Questionnaire (IBDQ)), symptoms of depression and anxiety (Symptom Checklist (SCL-90), Beck Depression Inventory (BDI), Hamilton Depression Rating Scale (HDRS)), immune activation (acute phase proteins (APP)), zinc and TRP availability were assessed before treatment and after 2, 4 and 8 weeks. Anti-TNF-alpha increased IBDQ scores and reduced all depression scores; however only SCL-90 depression scores remained decreased after correction for HBI. Positive APPs decreased, while negative APPs increased after treatment. After correction for HBI, both level and percentage of gamma fraction were associated with SCL-90 depression scores over time. After correction for HBI, patients with current/past depressive disorder displayed higher levels of positive APPs and lower levels of negative APPs and zinc. TRP availability remained invariant over time and there was no association between SCL-90 depression scores and TRP availability. Inflammatory reactions in CD are more evident in patients with comorbid depression, regardless of disease activity. Anti-TNF-alpha treatment in CD reduces depressive symptoms, in part independently of disease activity; there was no evidence that this effect was mediated by immune-induced changes in TRP availability.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Psychology, Clinical

A replication study of JTC bias, genetic liability for psychosis and delusional ideation

Cecile Henquet, Jim van Os, Lotta K. Pries, Christian Rauschenberg, Philippe Delespaul, Gunter Kenis, Jurjen J. Luykx, Bochao D. Lin, Alexander L. Richards, Berna Akdede, Tolga Binbay, Vesile Altinyazar, Berna Yalincetin, Guvem Gumus-Akay, Burcin Cihan, Haldun Soygur, Halis Ulas, Eylem S. Cankurtaran, Semra U. Kaymak, Marina M. Mihaljevic, Sanja S. Petrovic, Tijana Mirjanic, Miguel Bernardo, Gisela Mezquida, Silvia Amoretti, Julio Bobes, Pilar A. Saiz, Maria P. Garcia-Portilla, Julio Sanjuan, Eduardo J. Aguilar, Jose L. Santos, Estela Jimenez-Lopez, Manuel Arrojo, Angel Carracedo, Gonzalo Lopez, Javier Gonzalez-Penas, Mara Parellada, Nadja P. Maric, Cem Atbasoglu, Alp Ucok, Koksal Alptekin, Meram C. Saka, Celso Arango, Michael O'Donovan, Bart P. F. Rutten, Sinan Guloksuz

Summary: The study replicated that JTC bias is associated with familial liability for psychosis, and this association is stronger in individuals with higher levels of delusional ideation. The association between JTC bias and sibling status is not stronger in those with higher levels of hallucinatory experiences.

PSYCHOLOGICAL MEDICINE (2022)

Article Psychology, Clinical

Evidence, and replication thereof, that molecular-genetic and environmental risks for psychosis impact through an affective pathway

Jim van Os, Lotta-Katrin Pries, Margreet ten Have, Ron de Graaf, Saskia van Dorsselaer, Philippe Delespaul, Maarten Bak, Gunter Kenis, Bochao D. Lin, Jurjen J. Luykx, Alexander L. Richards, Berna Akdede, Tolga Binbay, Vesile Altinyazar, Berna Yalincetin, Guvem Gumus-Akay, Burcin Cihan, Haldun Soygur, Halis Ulas, Eylem Sahin Cankurtaran, Semra Ulusoy Kaymak, Marina M. Mihaljevic, Sanja Andric Petrovic, Tijana Mirjanic, Miguel Bernardo, Gisela Mezquida, Silvia Amoretti, Julio Bobes, Pilar A. Saiz, Maria Paz Garcia-Portilla, Julio Sanjuan, Eduardo J. Aguilar, Jose Luis Santos, Estela Jimenez-Lopez, Manuel Arrojo, Angel Carracedo, Gonzalo Lopez, Javier Gonzalez-Penas, Mara Parellada, Nadja P. Maric, Cem Atbasoglu, Alp Ucok, Koksal Alptekin, Meram Can Saka, Celso Arango, Michael O'Donovan, Bart P. F. Rutten, Sinan Guloksuz

Summary: The study reveals that the impact of genetic and non-genetic risk factors for schizophrenia on psychosis outcomes is partially mediated through an affective pathway.

PSYCHOLOGICAL MEDICINE (2022)

Article Psychiatry

Medication strategies in first episode psychosis patients: A survey among psychiatrists

Martijn J. Kikkert, Wim Veling, Lieuwe de Haan, Marieke J. H. Begemann, Mariken de Koning, Iris E. Sommer

Summary: There is a ongoing debate on the optimal timing of discontinuation of antipsychotic drugs for patients with first episode psychosis. Research shows that early discontinuation may be beneficial for some patients, but there is substantial practice variation among clinicians. Future research on long-term effects of early medication discontinuation can help guide evidence-based treatment decisions for first-episode patients.

EARLY INTERVENTION IN PSYCHIATRY (2022)

Article Psychology, Clinical

Longitudinal associations between alcohol use, smoking, genetic risk scoring and symptoms of depression in the general population: a prospective 6-year cohort study

N. de Boer, J. Vermeulen, B. Lin, J. van Os, M. ten Have, R. de Graaf, S. van Dorsselaer, M. Bak, B. Rutten, A. Batalla, S. Guloksuz, J. J. Luykx

Summary: This study aimed to examine the relationships between smoking, alcohol use, and mood disorders. The results showed that smoking and the number of cigarettes per day were positively associated with depressive symptoms, while moderate alcohol consumption was associated with a reduction in symptoms. Longitudinally, reductions in smoking behavior and alcohol consumption were associated with improvements in depressive symptoms.

PSYCHOLOGICAL MEDICINE (2023)

Article Psychology, Clinical

Context v. algorithm: evidence that a transdiagnostic framework of contextual clinical characterization is of more clinical value than categorical diagnosis

Jim van Os, Lotta-Katrin Pries, Margreet ten Have, Ron de Graaf, Saskia van Dorsselaer, Maarten Bak, Gunter Kenis, Bochao D. Lin, Nicole Gunther, Jurjen J. Luykx, Bart P. F. Rutten, Sinan Guloksuz

Summary: Background: Combining the contextual clinical characterization framework with categorical algorithm-based diagnosis can provide more clinical value to patients. Methods: Prospective analysis of data from multiple domains to predict the impact on care needs and healthcare outcomes. Results: The predictive power of the contextual clinical characterization components in joint models exceeded that of any individual component, and the polygenic risk scores did not contribute significantly to the models. Conclusion: The transdiagnostic framework of contextual clinical characterization is more valuable to patients than a categorical system of algorithmic ordering of psychopathology.

PSYCHOLOGICAL MEDICINE (2023)

Article Psychology, Experimental

Regaining Control of Your Emotions? Investigating the Mechanisms Underlying Effects of Cognitive Control Training for Remitted Depressed Patients

Kristof Hoorelbeke, Nathan Van den Bergh, Rudi De Raedt, Marieke Wichers, Casper J. Albers, Ernst H. W. Koster

Summary: Studies suggest that cognitive control training has potential as a preventive intervention for depression, but little is known about its underlying mechanisms. This study used an experimental manipulation of cognitive control to investigate its direct effects on affect, emotion regulation, residual symptomatology, and resilience in remitted depressed patients. The findings showed that cognitive control training had beneficial effects on rumination and played a causal role in emotion regulation. However, it did not have immediate effects on residual symptoms or resilience, and did not impact the complex interplay between these variables. Overall, the immediate effects of cognitive control training on daily functioning were limited.

EMOTION (2023)

Article Psychiatry

A Web-Based Application for Personalized Ecological Momentary Assessment in Psychiatric Care: User-Centered Development of the PETRA Application

Fionneke M. Bos, Lino von Klipstein, Ando C. Emerencia, Erwin Veermans, Tom Verhage, Evelien Snippe, Bennard Doornbos, Grietje Hadders-Prins, Marieke Wichers, Harriette Riese

Summary: This study aims to develop a web-based application called Personalized Treatment by Real-time Assessment (PETRA) for integrating personalized ecological momentary assessment (EMA) in psychiatric care. Through interviews, focus groups, and usability sessions, the requirements for the application were determined, and high-fidelity prototypes were continuously improved based on feedback. PETRA is unique in its codevelopment process, extensive personalization options, integration into electronic health record systems, transdiagnostic focus, and scientific foundation in EMA diaries and feedback. The clinical effectiveness of PETRA in routine mental health care requires further research.

JMIR MENTAL HEALTH (2022)

Review Psychiatry

Polygenic risk scores for predicting outcomes and treatment response in psychiatry: hope or hype?

Laura Fusar-Poli, Bart P. F. Rutten, Jim van Os, Eugenio Aguglia, Sinan Guloksuz

Summary: In recent years, the development of polygenic risk scores (PRSs) in psychiatry has been facilitated by the reduced costs and increased accessibility to large genome-wide association studies datasets. While PRS represent stable trait features with a normal distribution in the general population and are relatively easy to calculate in terms of time and costs, their real-world applicability is constrained by limitations such as low predictive power and lack of population diversity. Combining genomic and exposomic vulnerabilities with detailed clinical characterization is essential for personalized care in clinical psychiatry.

INTERNATIONAL REVIEW OF PSYCHIATRY (2022)

Article Psychology, Experimental

Daily dynamics of negative affect: indicators of rate of response to treatment and remission from depression?

Marieke A. Helmich, Marieke Wichers, Frenk Peeters, Evelien Snippe

Summary: This study found that instability and variability of negative affect were related to current and future depressive symptoms. Higher levels of negative affect and baseline symptom severity predicted a greater reduction in depressive symptoms during treatment, while lower levels of negative affect were associated with a higher likelihood of reaching remission.

COGNITION & EMOTION (2022)

Article Health Care Sciences & Services

Transitions in depression: if, how, and when depressive symptoms return during and after discontinuing antidepressants

Arnout C. Smit, Evelien Snippe, Laura F. Bringmann, H. J. Rogier Hoenders, Marieke Wichers

Summary: The purpose of this study is to explore the meaningful changes in individual patients who stop taking antidepressant medication. The results show that there are differences between macro-level and micro-level changes in depressive symptoms, highlighting the importance of combining qualitative and quantitative assessments.

QUALITY OF LIFE RESEARCH (2023)

Article Psychology, Clinical

Anticipating Transitions in Mental Health in At-Risk Youths: A 6-Month Daily Diary Study Into Early-Warning Signals

Marieke J. Schreuder, Catharina A. Hartman, Robin N. Groen, Arnout C. Smit, Marieke Wichers, Johanna T. W. Wigman

Summary: This study empirically investigated whether early-warning signals (EWSs) precede transitions towards psychopathology in at-risk youths. The results showed that EWSs had low sensitivity and moderate specificity, suggesting that their generic nature and clinical utility could not be substantiated.

CLINICAL PSYCHOLOGICAL SCIENCE (2022)

Article Psychology, Clinical

Detecting Impending Symptom Transitions Using Early-Warning Signals in Individuals Receiving Treatment for Depression

Marieke A. Helmich, Arnout C. Smit, Laura F. Bringmann, Marieke J. Schreuder, Albertine J. Oldehinkel, Marieke Wichers, Evelien Snippe

Summary: Drawing on dynamical systems theory, this study investigated whether early-warning signals in momentary affect could predict transitions to lower levels of depressive symptoms in individuals undergoing therapy for depression. The results showed that rising autocorrelation was found in 89% of individuals with transitions, and in a consistently higher proportion of the separate variables, compared to those without transitions. Rising variance was found for a few individuals, both preceding transitions and in individuals without transitions. In addition, some participants showed critical slowing down.

CLINICAL PSYCHOLOGICAL SCIENCE (2022)

Article Psychology, Clinical

Risk Ahead: Actigraphy-Based Early-Warning Signals of Increases in Depressive Symptoms During Antidepressant Discontinuation

Yoram K. Kunkels, Arnout C. Smit, Olga Minaeva, Evelien Snippe, Sandip V. George, Arie M. van Roon, Marieke Wichers, Harriette Riese

Summary: Discontinuation of antidepressants increases the risk of depressive symptoms. This study aimed to determine if transitions in depression were preceded by changes in actigraphy-based early-warning signals (EWSs), circadian-rhythm-based indicators, and mean activity levels. Data from 16 individuals with depression transitions and 9 without transitions were analyzed, showing that transitions were associated with increased EWSs. However, none of the tested risk indicators could confidently predict upcoming transitions in depression.

CLINICAL PSYCHOLOGICAL SCIENCE (2023)

Article Neurosciences

Estimating the Association Between Exposome and Psychosis as Well as General Psychopathology: Results From the ABCD Study

Lotta-Katrin Pries, Tyler M. Moore, Elina Visoki, Ingrid Sotelo, Ran Barzilay, Sinan Guloksuz

Summary: The exposome factors are associated with mental disorders, particularly with prenatal, perinatal, and childhood adversities, which can help understand neurodevelopmental psychopathology.

BIOLOGICAL PSYCHIATRY: GLOBAL OPEN SCIENCE (2022)

Review Neurosciences

Exposome and Trans-syndromal Developmental Trajectories Toward Psychosis

Ran Barzilay, Lotta-Katrin Pries, Tyler M. Moore, Raquel E. Gur, Jim van Os, Bart P. F. Rutten, Sinan Guloksuz

Summary: The prenatal period, early childhood, and adolescence are critical periods for brain development, and environmental exposures during these periods can have long-term effects on mental health. Psychosis spectrum disorder (PSD) is a developmental disorder that is influenced by both genetic and environmental factors. This review emphasizes the importance of studying the exposome and using a developmental lens to understand the environmental origins of PSD. It highlights the need for comprehensive assessments of environment, as well as the exploration of trans-syndromal manifestations, instead of focusing solely on categorical outcomes.

BIOLOGICAL PSYCHIATRY: GLOBAL OPEN SCIENCE (2022)

暂无数据